Treatment outcomes and prognostic factors in adult patients Slides: 7 Download presentation Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy by Jae-Ho Yoon, Sung-Soo Park, Young-Woo Jeon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, and Jong Wook Lee haematol Volume 104(2): 269 -276 January 31, 2019 © 2019 by Ferrata Storti Foundation Consort diagram of enrolled patients. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation Baseline characteristics and treatment outcome of patients with non-malignancy-associated secondary HLH (n=126). Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation Survival outcomes according to the cause of secondary hemophagocytic lymphohistiocytosis. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation Survival outcomes according to treatment response. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation Univariate and multivariate analyses for parameters affecting overall survival in non-malignancyassociated HLH. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation Survival outcomes according to hemophagocytic lymphohistiocytosis risk score. Jae-Ho Yoon et al. Haematologica 2019; 104: 269 -276 © 2019 by Ferrata Storti Foundation Periodontal management of medically compromised patientsAdult treatment panel iiiThe factors of care that patients can expect to receiveSquall line surface analysis chartWho prognostic scoring system gtnWho prognostic scoring system gtnDyspermyPalliative prognostic index